Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 7, 2013, Pages 527-533

  Lv, Deguan ^a   Li, Hening ^a   Chen, Linxi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

apelin; APJ; atherosclerosis; endothelial cell; vascular smooth cell

Indexed keywords

APELIN; APLN PROTEIN, HUMAN; APLNR PROTEIN, HUMAN; CELL ADHESION MOLECULE; CHEMOKINE; G PROTEIN COUPLED RECEPTOR; SIGNAL PEPTIDE;

ANIMAL; APJ; ATHEROSCLEROSIS; CELL ADHESION; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; REVIEW; VASCULAR SMOOTH CELL; VASCULAR SMOOTH MUSCLE;

APELIN; APJ; ATHEROSCLEROSIS; ENDOTHELIAL CELL; VASCULAR SMOOTH CELL;

ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; CELL ADHESION MOLECULES; CHEMOKINES; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84879935526     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt040     Document Type: Review

References (47)

1. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL and Shi X, et al. A human gene that shows identity with the gene encoding the angio-tensin receptor is located on chromosome 11. Gene 1993, 136: 355-360.
2. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX and Kawamata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251: 471-476.
3. Rittig K, Hildebrandt U, Thamer C, Staiger H, Peter A, Stefan N and Fritsche A, et al. Apelin serum levels are not associated with early atherosclerosis or fat distribution in young subjects with increased risk for type 2 diabetes. Exp Clin Endocrinol Diabetes 2011, 119: 358-361.
4. Tasci I, Dogru T, Naharci I, Erdem G, Yilmaz MI, Sonmez A and Bingol N, et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes2007, 115: 428-432.
5. Kourtis A, Gkiomisi A, Mouzaki M, Makedou K, Anastasilakis AD, Toulis KA and Gerou S, et al. Apelin levels in normal pregnancy. Clin Endocrinol 2011, 75: 367-371.
6. Tasci I, Erdem G, Ozgur G, Tapan S, Dogru T, Genc H and Acikel C, et al. LDL-cholesterol lowering increases plasma apelin in isolated hyper-cholesterolemia. Atherosclerosis 2009, 204: 222-228.
7. Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Gerasimidis T, Kostakis A and Liapis CD. Adipokines: a novel link between adiposity and carotid plaque vulnerability. Eur J Clin Invest 2012, 42: 1278-1286.
8. Pitkin SL, Maguire JJ, Kuc RE and Davenport AP. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 2010, 160: 1785-1795.
9. Peltonen T, Napankangas J, Vuolteenaho O, Ohtonen P, Soini Y, Juvonen T and Satta J, et al. Apelin and its receptor APJ in human aortic valve stenosis. J Heart Valve Dis 2009, 18: 644-652.
10. Fukushima H, Kobayashi N, Takeshima H, Koguchi W and Ishimitsu T. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide syn-thase pathway in Dahl rats with end-stage heart failure. J Cardiovasc Pharmacol 2010, 55: 83-88.
11. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R and Zheng L, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008, 118: 3343-3354.
12. Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H and Ishida J, et al. Requirement of apelin-apelin receptor system for oxida-tive stress-linked atherosclerosis. Am J Pathol 2007, 171: 1705-1712.
13. Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ and Kang Y, et al. Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol 2012, 362: 227-241.
14. Kadoglou NP, Vrabas IS, Kapelouzou A, Lampropoulos S, Sailer N, Kostakis A and Liapis CD, et al. The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes. Med Sci Monit 2012, 18: CR290-CR295.
15. Paternain L, de la Garza AL, Batlle MA, Milagro FI, Martinez JA and Campion J. Prenatal stress increases the obesogenic effects of a high-fat-sucrose diet in adult rats in a sex-specific manner. Stress 2013, 16: 220-232.
16. Meral C, Tascilar E, Karademir F, Tanju IA, Cekmez F, Ipcioglu OM and Ercin CN, et al. Elevated plasma levels of apelin in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2010, 23: 497-502.
17. Kadoglou NP, Tsanikidis H, Kapelouzou A, Vrabas I, Vitta I, Karayannacos PE and Liapis CD, et al. Effects of rosiglitazone and metfor-min treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Metabolism 2010, 59: 373-379.
18. Yu S, Zhang Y, Li MZ, Xu H, Wang Q, Song J and Lin P, et al. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. Chin Med J 2012, 125: 3440-3444.
19. Attane C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E and Guzman-Ruiz R, et al. Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 2012, 61: 310-320.
20. Karbowska A, Boratynska M and Klinger M. Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation? Postepy Hig Med Dosw (Online) 2009, 63: 485-491.
21. Hung WW, Hsieh TJ, Lin T, Chou PC, Hsiao PJ, Lin KD and Shin SJ. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther 2011, 25: 3-12.
22. Mao X, Su T, Zhang X, Li F, Qin X, Li X and Liao D. Apelin-13 promote monocytes adhesion to HUVECs via PI3K signaling. Prog Biochem Biophys 2011, 38: 1162-1170.
23. Lu Y, Zhu X, Liang GX, Cui RR, Liu Y, Wu SS and Liang QH, et al. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-kappaB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids 2012; 43: 2125-2236.
24. Li X, Zhang X, Li F, Chen L, Li L, Qin X and Gao J, et al. 14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells. Acta Biochim Biophys Sin 2010, 42: 403-409.
25. Li F, Li LF, Qin XP, Pan WN, Feng F, Chen F and Zhu BY, et al. The study of vascular smooth muscle cells proliferation stimulated by apelin-13. Chin Pharmacol Bull 2007, 23: 949-953.
26. Li F, Li L, Qin X, Pan W, Feng F, Chen F and Zhu B, et al. Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1. Front Biosci 2008, 13: 3786-3792.
27. Liu C, Su T, Li F, Li L, Qin X, Pan W and Feng F, et al. PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13. Acta Biochim Biophys Sini 2010, 42: 396-402.
28. Pan W, Li F, Mao X, Qin X, Deng Y, Feng F and Chen F, et al. 14-3-3 protein is involved in ERK1/2 signaling transduction pathway of rat vascular smooth muscle cells proliferation induced by apelin-13. Prog Biochem Biophys 2011, 38: 1153-1161.
29. Mao X, Li L, Gao J, Yang L, Liu W, Qin X and Chen L. Apelin-13 promotes proliferation of vascular smooth muscle cells by down regulating caveolae expression. J Clin Rehabil Tissue Eng Res 2011, 15: 8603-8608.
30. Li L, Li F and Li F. NOX4-derived reactive oxygen species drive apelin-13-induced vascular smooth muscle cell proliferation via the ERK pathway. Int J Pept Res Ther 2011, 17: 307-315.
31. Kunduzova O, Alet N, Delesque-Touchard N, Millet L, Castan-Laurell I, Muller C and Dray C, et al. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J 2008, 22: 4146-4153.
32. Visser YP, Walther FJ, Laghmani el H, Laarse A and Wagenaar GT. Apelin attenuates hyperoxic lung and heart injury in neonatal rats. Am J Respir Crit Care Med 2010, 182: 1239-1250.
33. Masri B, van den Berghe L, Sorli C, Knibiehler B and Audigier Y. Apelin signalisation and vascular physiopathology. J Soc Biol 2009, 203: 171-179.
34. Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H and Hegedus B, et al. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. J Thorac Oncol 2010, 5: 1120-1129.
35. Kasai A. Pathological role of apelin in angiogenic eye disease. Yakugaku Zasshi 2011, 131: 1201-1206.
36. del Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, Larrivee B and Breant C, et al. Identification and functional analysis of endothelial tip cell-enriched genes. Blood 2010, 116: 4025-4033.
37. Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, Berzigotti A, Bosch J and Fernandez M. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J hepatol 2009, 50: 296-305.
38. Principe A, Melgar-Lesmes P, Fernandez-Varo G, del Arbol LR, Ros J, Morales-Ruiz M and Bernardi M, et al. The hepatic apelin system: a new therapeutic target for liver disease. Hepatol 2008, 48: 1193-1201.
39. Li L, Zeng H and Chen JX. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol 2012, 303: H605-H618.
40. Michailidou Z, Turban S, Miller E, Zou X, Schrader J, Ratcliffe PJ and Hadoke PW, et al. Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11beta-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice. J Biol Chem 2012, 287: 4188-4197.
41. Kasai A, Ishimaru Y, Kinjo T, Satooka T, Matsumoto N, Yoshioka Y and Yamamuro A, et al. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis. Arterioscler Thromb Vasc Biol 2010, 30: 2182-2187.
42. Koguchi W, Kobayashi N, Takeshima H, Ishikawa M, Sugiyama F and Ishimitsu T. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure. Circulation 2012, 76: 137-144.
43. Leeper NJ, Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA and Tsao PS, et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol 2009, 296: H1329-H1335.
44. Kidoya H, Naito H and Takakura N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 2010, 115: 3166-3174.
45. Heinonen MV, Laaksonen DE, Karhu T, Karhunen L, Laitinen T, Kainulainen S and Rissanen A, et al. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009, 19: 626-633.
46. Leal VO, Lobo JC, Stockler-Pinto MB, Farage NE, Calixto A, Geloneze B and Mafra D. Apelin: a peptide involved in cardiovascular risk in hemodi-alysis patients? Ren Fail 2012, 34: 577-581.
47. Khan P, Maloney PR, Hedrick M, Gosalia P, Milewski M, Li L and Roth GP, et al. Functional agonists of the apelin (APJ) receptor. Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD), 2010.